DOCSLIB.ORG

Bloom Syndrome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bloom Syndrome Proc. Natl. Acad. Sci. USA Vol. 91, pp. 6669-6673, July 1994 Genetics Bloom syndrome: An analysis of consanguineous families assigns the locus mutated to chromosome band 15q26.1 (homozygosity mapping/nka analysls/genomic instability/chromosome-breakge syndrome) JAMES GERMAN*, ANNE MARIE ROE*, MARK F. LEPPERTt, AND NATHAN A. ELLIS* *Laboratory of Human Genetics, New York Blood Center, New York, NY 10021; and tDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84132 Communicated by Stanley M. Gartler, March 28, 1994 ABSTRACT By the principle of identity by descent, pa- tured BS cell lines exhibit hypersensitivity to certain DNA- rental consanguinity in individuals with rare recessively trans- damaging agents-e.g., mitomycin C, N-nitroso-N-ethyl- mitted disorders dictates homozygosity notjust at the mutated urea, and ethyl methanesulfonate (7-9). (iv) Altered activity disease-assoiated locus but also at sequences that flank that of several enzymes employed in DNA replication, DNA locus closely. In 25 of 26 individuals with Bloom syndrome repair, or both have been detected in some BS cell lines, examined whose parents were related, a polymorphic tetranu- including DNA ligase I, uracil DNA glycosylase, topoisom- cleotide repeat in an intron of the protooncogene FES was erase, 06-methylguanine methyltransferase, N-methylpurine homozygous, far more often than expected (P < 0.0001 by x2). DNA glycosylase, thymidylate synthetase, and superoxide Therefore, BLM, the gene that when mutated gives rise to dismutase (10-18). Therefore, elucidation of the primary Bloom syndrome, is tightly linked to FES, a gene whose defect probably will identify a factor ofcentral importance in chromosome position Is known to be l5q26.1. This successful the maintenance ofgenomic stability. The factor defective in approach to the aignment ofthe Bloom syndrome locus to one BS should have the potential ofaltering the activities ofmany short segment of the human genome simultaneously (i) dem- enzymes whose coordinated action ensures that stability. onstrates the power ofhomozygosity mapping and (it) becomes The investigation reported here permits the assignment of the first step in a "reverse" genetics defmition of the primary BLM to a specific sub-band-15q26.1-by the analysis of defect in Bloom syndrome. DNA from a small population ofpersons with BS who are the progeny ofconsanguineous marriages. This regional mapping Bloom syndrome (BS) (1, 2) is a rare autosomal recessive of BLM was carried out as part of a larger effort aimed at disorder the predominating clinical feature of which is a identifying BS's primary defect. In addition, it serves as a test well-proportioned smallness ofthe body. The locus mutated, of the value of an until-now-little-used method of detecting here named BLM, has long been recognized to be of central linkage in man, homozygosity mapping.* importance in the maintenance of genomic stability because persons with BS, blm/blm, feature a remarkable degree of genomic instability. In somatic cells having such a mutator MATERIALS AND METHODS genotype, increased numbers of different types of spontane- Families. Between 1960 and 1991, genetic and clinical ous mutations arise at various sites, mutations that qualita- information from essentially all families throughout the world tively are similar to those that arise spontaneously in normal affected with BS has been accumulated in files maintained in individuals. In addition to locus-specific mutations, in- the Laboratory of Human Genetics at the New York Blood creased numbers of microscopically visible chromosome Center-the Bloom's Syndrome Registry (20-23). From the mutations at randomly distributed sites are present in meta- outset, stringent clinical and cytogenetic diagnostic criteria phase chromosomes-gaps, breaks, and rearrangements. In for accessioning persons to the Registry have been utilized. particular, a striking excess ofchromatid exchanges occurs in For the present investigation, those families from the Reg- BS, including homologous chromatid interchange which is istry were studied (i) in which the parents of the affected cytogenetic evidence of somatic crossing-over (3); therefore, person(s) were known to be related and (ii) from whom cells a mutation that does arise at any particular site in a BS of some type from the affected person(s) had been stored or somatic cell also is at an increased risk ofbecoming homozy- could now be obtained. Fig. 1 depicts the 21 families exam- gous. Other than the generalized growth deficiency ofclinical ined. The relatedness ofthe parents varies from first to fourth BS, which itself may be the consequence of an excessive cousins-e.g., the 52(PaDu) and 30(MaKa) families, respec- number oflethal mutations, the most important manifestation tively. The geographic or ethnic origins ofthe families are the of the genomic instability of the somatic cells is neoplasia; following: non-Jewish American with mixed Western Euro- cancers ofa wide variety of sites and types emerge unusually pean (six) and West African (two) ancestry; non-Jewish early and frequently in persons with BS. Italian (three), German (two), Turkish (two), Japanese (two), The primary defect in BS is unknown, and this has limited French Canadian (one), and Spanish (one); and Ashkenazi its usefulness as a model for studying neoplastic transforma- (one) and Sephardi (one) Jewish. tion and progression. Results of many studies do point to a Sources of DNA. Lymphoblastoid cell lines and blood disturbance of DNA replication. (i) The cytogenetic abnor- leukocytes stored in liquid nitrogen in the Bloom's Syndrome malities (4) are best explained on the basis of excessive Registry were the major source ofDNA. In some cases fresh exchange of chromatids via an error-prone mechanism acti- whole blood samples were obtained specifically for this vated during S-phase replication. (ii) Replication-fork pro- study, and in one case, archival (pathology) material of a gression is retarded (5), and an unusual size distribution of deceased person was employed. DNA replication intermediates is found (6). (iii) Some cul- Abbreviations: BS, Bloom syndrome; lod, logarithm of odds. The publication costs ofthis article were defrayed in part by page charge *The data reported here were presented as a poster at the 42nd payment. This article must therefore be hereby marked "advertisement" Annual Meeting of the American Society of Human Genetics, San in accordance with 18 U.S.C. §1734 solely to indicate this fact. Francisco, November 9-13, 1992 (19). 6669 Downloaded by guest on September 28, 2021 6670 Genetics: German et al. Proc. Natl. Acad. Sci. USA 91 (1994) 5(JaOa) " 7(RoTa) * 17(ChSm) * 21(RaRe) 22(El~a) 3*M~)*' 51(KeMc) M 00 ao ba rd0 *0 0 pi. 60(AnDa) 61(DoHop) ' 74(OmAy) 81(MaGrou) * 92(VaBia) FIG. 1. Abbreviated pedigrees of the families studied. Each fam- * ** ** ** ily is identified by the index case's designation in the Bloom's Syn- 6T , drome Registry (20-23). For ho- th0 * l mozygosity mapping, the geno- type of every individual with BS * 4 was examined, save from the sec- 96(HiOk) 11O(MaKu) 1IMDaDern) - 122(RoHer) -* 127(TaLAI) 14K) - 149(Se~ - ond affected siblings in the fami- D lies of 17(ChSm) and 149(SeSat). 0 Dots indicate individuals from [uT aT) . 0~ whom genotype information was q analyzed by the program LINK- * 0 * AGE. Filled symbols, individuals 0 with BS; asterisk, a family in the * 0 initial phase of the study (see text). DNA Genotyping. Selected DNA probes for loci known to one parent in each pedigree was duplicated, arbitrarily the map to chromosome 15 were obtained (Fig. 2) for use in mother of the affected. hybridization studies. For Southern analysis, 1-10 pug of To estimate the recombination fraction, the total numberof DNA was digested with restriction enzymes according to the meioses (the denominator in the fraction) was estimated by supplier's recommendations, and the DNA fragments were counting each ancestor in the loop ofa pedigree (Fig. 1) as one separated by electrophoresis through 0.8% agarose (FMC) meiotic event, except for the ancestor at the top of the loop gels in 89 mM Tris/89 mM boric acid/2 mM EDTA. DNA was who was counted as two, and summing over all pedigrees. transferred to Hybond N+ nylon membrane (Amersham) as Affected siblings for which genotypic information was ob- described (27). Hybridization was 1 M NaCl/1% SDS/10%o tained were counted as two additional meioses. The total was dextran sulfate containing sheared and denatured salmon then multiplied by the frequency of homozygosity of the testis DNA (0.25 mg/ml) and denatured labeled probe (2-10 polymorphisms under study; this adjustment was made be- ng/ml). Probes were labeled by the random hexamer method cause recombination between BLM and any test locus would using [a-32P]dCTP (28). When necessary, the probe was not be detected in homozygotes. The number of heterozy- prehybridized with Cotl DNA (BRL) in 1 ml ofhybridization gotes at any test locus was taken to be the number of solution according to the manufacturer's instructions. recombinants and became the numerator of the fraction. PCR was carried out in 10-25 A4 of 50 mM KCI/0.5-2.5 mM MgCl2/10 mM Tris HCl, pH 8.3/0.1% gelatin/100 nM THEORY tetramethylammonium chloride/200 jAM dNTPs (Pharmacia) with 1.25 units of Taq polymerase (Cetus or Boehringer The principle behind the approach to detecting linkage by Mannheim) and 4 pmol of each oligonucleotide primer. homozygosity mapping is the following. An individual with Oligonucleotide sequences specific for selected loci on chro- BS who is the offspring of a consanguineous union is ex- mosome 15 (Fig. 2) were obtained from Human Gene Map- pected to be homozygous for the mutation at BLM- ping 11 (29); sequence information concerning loci ACTC, specifically, not to be a compound heterozygote should more CYP, FBN, and D15S87 was generously provided by A.
Load more

Recommended publications
  • Open Full Page
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders Michael F. Walsh1, Vivian Y. Chang2, Wendy K. Kohlmann3, Hamish S. Scott4, Christopher Cunniff5, Franck Bourdeaut6, Jan J. Molenaar7, Christopher C. Porter8, John T. Sandlund9, Sharon E. Plon10, Lisa L. Wang10, and Sharon A. Savage11 Abstract DNA repair syndromes are heterogeneous disorders caused by around the world to discuss and develop cancer surveillance pathogenic variants in genes encoding proteins key in DNA guidelines for children with cancer-prone disorders. Herein, replication and/or the cellular response to DNA damage. The we focus on the more common of the rare DNA repair dis- majority of these syndromes are inherited in an autosomal- orders: ataxia telangiectasia, Bloom syndrome, Fanconi ane- recessive manner, but autosomal-dominant and X-linked reces- mia, dyskeratosis congenita, Nijmegen breakage syndrome, sive disorders also exist. The clinical features of patients with DNA Rothmund–Thomson syndrome, and Xeroderma pigmento- repair syndromes are highly varied and dependent on the under- sum. Dedicated syndrome registries and a combination of lying genetic cause. Notably, all patients have elevated risks of basic science and clinical research have led to important in- syndrome-associated cancers, and many of these cancers present sights into the underlying biology of these disorders. Given the in childhood. Although it is clear that the risk of cancer is rarity of these disorders, it is recommended that centralized increased, there are limited data defining the true incidence of centers of excellence be involved directly or through consulta- cancer and almost no evidence-based approaches to cancer tion in caring for patients with heritable DNA repair syn- surveillance in patients with DNA repair disorders.
    [Show full text]
  • CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions Christopher C
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions Christopher C. Porter1, Todd E. Druley2, Ayelet Erez3, Roland P. Kuiper4, Kenan Onel5, Joshua D. Schiffman6, Kami Wolfe Schneider7, Sarah R. Scollon8, Hamish S. Scott9, Louise C. Strong10, Michael F. Walsh11, and Kim E. Nichols12 Abstract Leukemia, the most common childhood cancer, has long been patients. The panel recognized that for several conditions, recognized to occasionally run in families. The first clues about routine monitoring with complete blood counts and bone the genetic mechanisms underlying familial leukemia emerged marrow evaluations is essential to identify disease evolution in 1990 when Li-Fraumeni syndrome was linked to TP53 muta- and enable early intervention with allogeneic hematopoietic tions. Since this discovery, many other genes associated with stem cell transplantation. However, for others, less intensive hereditary predisposition to leukemia have been identified. surveillance may be considered. Because few reports describ- Although several of these disorders also predispose individuals ing the efficacy of surveillance exist, the recommendations to solid tumors, certain conditions exist in which individuals are derived by this panel are based on opinion, and local expe- specifically at increased risk to develop myelodysplastic syn- rience and will need to be revised over time. The development drome (MDS) and/or acute leukemia. The increasing identifica- of registries and clinical trials is urgently needed to enhance tion of affected individuals and families has raised questions understanding of the natural history of the leukemia-predis- around the efficacy, timing, and optimal methods of surveil- posing conditions, such that these surveillance recommenda- lance.
    [Show full text]
  • Disease Reference Book
    The Counsyl Foresight™ Carrier Screen 180 Kimball Way | South San Francisco, CA 94080 www.counsyl.com | [email protected] | (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient Congenital Adrenal Hyperplasia .................................................................................................................................................................................... 8 21-hydroxylase-deficient Congenital Adrenal Hyperplasia ...........................................................................................................................................................................................10 6-pyruvoyl-tetrahydropterin Synthase Deficiency ..........................................................................................................................................................................................................12 ABCC8-related Hyperinsulinism........................................................................................................................................................................................................................................ 14 Adenosine Deaminase Deficiency .................................................................................................................................................................................................................................... 16 Alpha Thalassemia.............................................................................................................................................................................................................................................................
    [Show full text]
  • Blueprint Genetics Bone Marrow Failure Syndrome Panel
    Bone Marrow Failure Syndrome Panel Test code: HE0801 Is a 135 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of inherited bone marrow failure syndromes. The genes on this panel are included in the Comprehensive Hematology Panel. About Bone Marrow Failure Syndrome Inherited bone marrow failure syndromes (IBMFS) are a diverse set of genetic disorders characterized by the inability of the bone marrow to produce sufficient circulating blood cells. Bone marrow failure can affect all blood cell lineages causing clinical symptoms similar to aplastic anemia, or be restricted to one or two blood cell lineages. The clinical presentation may include thrombocytopenia or neutropenia. Hematological manifestations may be accompanied by physical features such as short stature and abnormal skin pigmentation in Fanconi anemia and dystrophic nails, lacy reticular pigmentation and oral leukoplakia in dyskeratosis congenita. Patients with IBMFS have an increased risk of developing cancer—either hematological or solid tumors. Early and correct disease recognition is important for management and surveillance of the diseases. Currently, accurate genetic diagnosis is essential to confirm the clinical diagnosis. The most common phenotypes that are covered by the panel are Fanconi anemia, Diamond-Blackfan anemia, dyskeratosis congenita, Shwachman-Diamond syndrome and WAS-related disorders. Availability 4 weeks Gene Set Description Genes in the Bone Marrow Failure Syndrome Panel and their clinical significance
    [Show full text]
  • Pediatric Photosensitivity Disorders Dr
    FAST FACTS FOR BOARD REVIEW Series Editor: William W. Huang,MD,MPH W. Series Editor:William Swetha N.Pathak,MD;JacquelineDeLuca,MD Pediatric PhotosensitivityDisorders Table 1. Pediatric Photosensitivity Disorders Disease Pathophysiology Clinical Features Management/Prognosis Other/Pearls Actinic prurigo Strong association Pruritic crusted papules Phototesting: lesions Native Americans, (hydroa aestivale, with HLA-DR4 and nodules in both provoked by UVA or UVB; especially mestizos; Hutchinson (HLA-DRB1*0401/0407); sun-exposed and less spontaneous resolution hardening does not summer prurigo) may be a persistent frequently nonexposed may occur during late occur; histopathology: variant of PMLE sites (ie, buttocks); heal adolescence; may follow dermal perivascular (delayed-type with scarring; mucosal a chronic course that mononuclear cell hypersensitivity) and conjunctival persists in adulthood; infiltrate, lacks papillary from UVA or UVB involvement, with cheilitis photoprotection; topical dermal edema, can see often an initial or only corticosteroids and lymphoid follicles feature; worse in summer topical tacrolimus; from lip biopsies; but can extend to winter NB-UVB or PUVA; occurs hours to cyclosporine or days following azathioprine; thalidomide sun exposure (treatment of choice) for (vs solar urticaria) resistant disease noconflictofinterest. The authorsreport Long Beach,California. Center, LaserSkinCare DeLucaisfrom Dr. North Carolina. Winston-Salem, University, Forest Wake Pathakisfrom Dr. Bloom syndrome AR; BLM (encodes Malar telangiectatic
    [Show full text]
  • Natural Gene Therapy May Occur in All Patients with Generalized Non-Herlitz Junctional Epidermolysis Bullosa with COL17A1 Mutations Anna M.G
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector ORIGINAL ARTICLE Natural Gene Therapy May Occur in All Patients with Generalized Non-Herlitz Junctional Epidermolysis Bullosa with COL17A1 Mutations Anna M.G. Pasmooij1, Miranda Nijenhuis1, Renske Brander1 and Marcel F. Jonkman1 Mutations in the type XVII collagen gene (COL17A1) result in the blistering disorder non-Herlitz junctional epidermolysis bullosa (JEB-nH). The incidence of revertant mosaicism, also called ‘‘natural gene therapy’’, was identified in a cohort of 14 patients with JEB-nH caused by COL17A1 mutations in the Netherlands. Five different in vivo reversions, all correcting the germ-line COL17A1 mutation c.2237delG in exon 30, were found in four mosaic JEB-nH patients. The correcting DNA changes involved a wide variety of somatic mutations, from which an indel mutation (c.2228-101_2263 þ 70delins15) and a large deletion of 2,165 base pairs (c.2227 þ 153_2336- 318del) have not been previously observed in patients with revertant mosaicism. Our results show that there is no preference for a repair mechanism. Moreover, revertant mosaicism was confirmed on a DNA level in 6 out of 10 generalized JEB-nH patients. Further, photo-material and clinical history of the other four generalized JEB-nH patients demonstrated that each patient has revertant skin patches. In contrast, revertant mosaicism was not detected in the four localized JEB-nH patients. The fact that so many, if not all, generalized JEB-nH COL17A1 patients have revertant patches offers opportunities for cell therapies in which the patient’s own naturally corrected cells are used as a source.
    [Show full text]
  • Nationwide Survey of Baller‑Gerold Syndrome in Japanese Population
    3222 MOLECULAR MEDICINE REPORTS 15: 3222-3224, 2017 Nationwide survey of Baller‑Gerold syndrome in Japanese population HIDEO KANEKO1, RIE IZUMI2, HIROTSUGU ODA3, OSAMU OHARA4, KIYOKO SAMESHIMA5, HIDENORI OHNISHI6, TOSHIYUKI FUKAO6 and MICHINORI FUNATO1 1Department of Clinical Research, National Hospital Organization Nagara Medical Center, Gifu 502-8558; 2Niigata Prefecture Hamagumi Medical Rehabilitation Center for Children, Niigata 951-8121; 3Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences (RIKEN‑IMS), Yokohama, Kanagawa 230-0045; 4Department of Technology Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818; 5Division of Medical Genetics, Gunma Children's Medical Center, Shibukawa, Gunma 377‑8577; 6Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan Received July 19, 2016; Accepted March 10, 2017 DOI: 10.3892/mmr.2017.6408 Abstract. Baller-Gerold syndrome (BGS) is a rare autosomal mutations of the RECQL4 gene causes Rothmund-Thomson genetic disorder characterized by radial aplasia/hypoplasia syndrome (3,4). and craniosynostosis. The causative gene for BGS encodes However, mutations in the RECQL4 gene have been associ- RECQL4, which belongs to the RecQ helicase family. To ated with two other recessive disorders: One is RAPADILINO understand BGS patients in Japan, a nationwide survey was syndrome (OMIM 266280) which is characterized by radial conducted, which identified 2 families and 3 patients affected hypoplasia, patella hypoplasia and arched plate, diarrhoea and by the syndrome. All the three patients showed radial defects dislocated joints, little size and limb malformation, slender and craniosynostosis. In one patient who showed a dislocated nose and normal intelligence (4). The other is Baller-Gerold joint of the hip and flexion contracture of both the elbow syndrome (BGS) (OMIM 218600) characterized by radial joints and wrists at birth, a homozygous large deletion in the aplasia/hypoplasia and craniosynostosis (5).
    [Show full text]
  • Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
    92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, ␤3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣6␤4 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1
    [Show full text]
  • A Young Diabetic Case with Bloom Syndrome a Case of Dyskeratosis
    J Clin Res Pediatr Endocrinol 2015;7(Suppl 2):77-92 A Young Diabetic Case with Bloom Syndrome A Case of Dyskeratosis Congenita Associated with Hypothyroidism and Hypogonadism Nilüfer Özdemir Kutbay1, Banu Şarer Yürekli1, Mehmet Erdoğan1, Şevki Çetinkalp1, Nilüfer Özdemir Kutbay1, Zehra Erdemir2, Özgür Çoğulu2, A. Gökhan Özgen1, Banu Şarer Yürekli1, Emin Karaca3, L. Füsun Saygılı1 Mehmet Erdoğan1, Şevki Çetinkalp1, Gülşen Kandiloğlu4, A. Gökhan Özgen1, 1Ege University Faculty of Medicine, Department of Ferda Özkınay3, L. Füsun Saygılı1 Endocrinology, İzmir, Turkey 1Ege University Faculty of Medicine, Department of 2Ege University Faculty of Medicine, Department of Medical Endocrinology, İzmir, Turkey Genetics, İzmir, Turkey 2Ege University Faculty of Medicine, Department of Internal Medicine, İzmir, Turkey Bloom syndrome (BS) is a rare autosomal recessive 3Ege University Faculty of Medicine, Department of Medical disorder characterized by short stature, telangiectasias, Genetics, İzmir, Turkey and a rash on the face triggered by the sun. Other clinical 4Ege University Faculty of Medicine, Department of Pathology, features include immune deficiency and predisposition to İzmir, Turkey the development of cancer and diabetes. We present this Dyskeratosis congenital (DC) is a rare multisystemic case as the diabetic BS is rare. disease characterized by skin atrophy, pigmentation, nail Case: A 20-year-old male patient who had diabetes dystrophy, leukoplakia in mucous membrane, bone marrow for 3 years was admitted. The patient had complaints of failure, and tendency to malignancy. We present a rare case rash on sun-exposed parts of the body such as cheeks of DC associated with hypothyroidism and hypogonadism. and arms since he was 2 years old. In his medical history, Case: A 30-year-old male patient was referred to us with he was found to be followed up for growth failure.
    [Show full text]
  • Oral Manifestation of Genodermatoses L
    Journal of Medicine, Radiology, Pathology & Surgery (2017), 4, 22–27 NARRATIVE REVIEW Oral manifestation of genodermatoses L. Kavya, S. Vandana, Swetha Paulose, Vishwanath Rangdhol, W. John Baliah, T. Dhanraj Department of Oral Medicine and Radiology, Indira Gandhi Institute of Dental Sciences, Pudhucherry, India Keywords Abstract Genodermatoses, mutation, oral Genodermatoses are inherited dermatological disorders associated with the structure manifestation and functions of skin and its appendages. Several genodermatoses presenting with Correspondence multisystem involvement lead to increased morbidity and mortality. Dermatological Dr. L. Kavya, Department of Oral Medicine and diseases, besides including the skin and its supplements may also involve the oral cavity, Radiology, Indira Gandhi Institute of Dental which deserves special attention considering that they may be the only presenting sign Sciences, Pudhucherry, India. of these disorders. The important aspect to be noted about these disorders is the rarity Phone: +91-9442902745. of the conditions and lack of awareness among the population which are the major E-mail: [email protected] drawbacks in the early diagnosis and prompt management of these diseases. This review intends to outline various genodermatoses with their characteristic oral manifestations. Received: 11 April 2017; Accepted: 15 May 2017 doi: 10.15713/ins.jmrps.97 Introduction hence, it is simplified under three classifications based on its distinct features. Genodermatoses or genetic diseases are a group of inherited According to William et al. 2005:[3] skin disorders with a collection of cutaneous and systemic signs 1. Chromosomal and symptoms. In the oral cavity, a wide spectrum of diseases 2. Single gene occurs due to genetic modifications ranging from developmental 3.
    [Show full text]
  • Bloom Syndrome
    Bloom syndrome What is Bloom syndrome? Bloom syndrome is an inherited disease characterized by short stature, sun-sensitivity, and increased risk of cancer. Cancer is caused by the instability of DNA during cell division and the inability of the body to repair damaged DNA. Symptoms associated with Bloom syndrome are the result of unrepaired gaps and breaks in the genetic material, which impairs normal cell functions.1 Bloom syndrome is also known as Bloom-Torre-Mackacek syndrome and congenital telangiectatic erythema.2 What are the symptoms of Bloom syndrome and what treatment is available? The symptoms of Bloom syndrome may include:3 • Prenatal and postnatal growth deficiency, which may be the only symptom apparent at birth, and short stature in all stages of life • Feeding difficulties in infancy • Gastrointestinal reflux, which may contribute to repeated lung and ear infections • Red (butterfly-shaped) rash that appears after sun exposure, typically on the face and less often, on the hands, and forearms • Immunodeficiency • Learning problems • Infertility in males and early menopause in females • Serious medical complications that appear at unusually early ages, including chronic obstructive pulmonary disease and diabetes mellitus • Increased risk of multiple cancers at an early age (average age of diagnosis 26.6 years, range (<1-49) There is no cure for Bloom syndrome at this time. Lifespan may be shortened, most commonly by cancer, but survival to the teens or 20’s is expected. Preventative management is important, such as avoiding sun exposure and having regular cancer screening from a young age. Treatment focuses on managing symptoms, preventing secondary complications, and surveillance.3 How is Bloom syndrome inherited? Bloom syndrome is an autosomal-recessive disease caused by mutations in the BLM gene.1 An individual who inherits one BLM mutation is a carrier and is not expected to have related health problems.
    [Show full text]
  • DNA Repair Disorders
    178 Arch Dis Child 1998;78:178–184 REGULAR REVIEW Arch Dis Child: first published as 10.1136/adc.78.2.178 on 1 February 1998. Downloaded from DNA repair disorders C GeoVrey Woods Over the past 30 years a number of rare DNA Exogenous DNA mutants have been classi- repair disorder phenotypes have been deline- cally divided into ultraviolet irradiation, ionis- ated, for example Bloom’s syndrome, ataxia ing irradiation, and alkylating agents. telangiectasia, and Fanconi’s anaemia. In each Ultraviolet irradiation and alkylating agents phenotype it was hypothesised that the under- can cause a number of specific base changes, as lying defect was an inability to repair a particu- well as cross linking bases together. Ionising lar type of DNA damage. For some of these irradiation is thought to generate the majority disorders this hypothesis was supported by of its mutational load by free radical produc- cytogenetics studies using DNA damaging tion. A wide variety of other DNA damaging agents, these tests defined the so-called chro- agents, both natural and man made, are mosome breakage syndromes. A number of the known, many are used as chemotherapeutic aetiological genes have recently been cloned, agents. confirming that some DNA repair disorder phenotypes can be caused by more than one DNA repair gene and vice versa. This review deals only with The DNA double helix seems to have evolved the more common DNA repair disorders. so that mutations, even as small as individual Rarer entities, such as Rothmund-Thomson base damage, are easily recognised. Such syndrome and dyskeratosis congenita, are recognition is usually by a change to the physi- excluded.
    [Show full text]